Editorial
Nature Medicine 14, 1 (2008)
doi:10.1038/nm0108-1
Turning a blind eye
Abstract
A new proposal might allow drug makers to promote off-label uses of their products by distributing medical publications to US doctors. Stronger rules could assure that information—not propaganda—drives doctors' prescription practices.